APLIF
Price:
$0.015
Market Cap:
$3.03M
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for F...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
APLIF
According to Appili Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.50. This represents a change of -675.83% compared to the average of 0.26 of the last 4 quarters.
The mean historical PE Ratio of Appili Therapeutics Inc. over the last ten years is -4.29. The current -1.50 PE Ratio has changed 3.40% with respect to the historical average. Over the past ten years (40 quarters), APLIF's PE Ratio was at its highest in in the March 2025 quarter at 4.65. The PE Ratio was at its lowest in in the June 2018 quarter at -13.87.
Average
-4.29
Median
-4.31
Minimum
-13.81
Maximum
-0.32
Discovering the peaks and valleys of Appili Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 128.08%
Maximum Annual PE Ratio = -0.32
Minimum Annual Increase = -93.05%
Minimum Annual PE Ratio = -13.81
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.62 | 44.05% |
| 2024 | -1.12 | 128.08% |
| 2023 | -0.49 | 54.39% |
| 2022 | -0.32 | -93.05% |
| 2021 | -4.59 | 6.41% |
| 2020 | -4.31 | -22.96% |
| 2019 | -5.59 | -17.11% |
| 2018 | -6.75 | -51.13% |
The current PE Ratio of Appili Therapeutics Inc. (APLIF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.08
5-year avg
-1.63
10-year avg
-4.29
Appili Therapeutics Inc.’s PE Ratio is less than Algernon Pharmaceuticals Inc. (-1.32), less than ReNeuron Group plc (-0.01), less than Ayala Pharmaceuticals, Inc. (-0.01), less than Universal Ibogaine Inc. (-0.18), greater than Restart Life Sciences Corp. (-2.72), less than Regen BioPharma, Inc. (-0.25), greater than VG Life Sciences Inc. (-3.15), greater than America Great Health (-1.95), greater than Imagion Biosystems Limited (-1.82), less than Health Sciences Group, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.32 | $1.92M | |
| -0.01 | $62.89K | |
| -0.01 | $4.41M | |
| -0.18 | $2.06M | |
| -2.72 | $2.27M | |
| -0.25 | $315.55K | |
| -3.15 | $2.11M | |
| -1.95 | $2.12M | |
| -1.82 | $2.21M | |
| -0.00 | $187.09K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Appili Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Appili Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Appili Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Appili Therapeutics Inc. (APLIF)?
What is the highest PE Ratio for Appili Therapeutics Inc. (APLIF)?
What is the 3-year average PE Ratio for Appili Therapeutics Inc. (APLIF)?
What is the 5-year average PE Ratio for Appili Therapeutics Inc. (APLIF)?
How does the current PE Ratio for Appili Therapeutics Inc. (APLIF) compare to its historical average?